Brief: Paxman Supplements Application For Expanded FDA Clearance In USA
May 8 (Reuters) - PAXMAN AB (PUBL) PAX.ST :
* PAXMAN SUPPLEMENTS APPLICATION FOR EXPANDED FDA CLEARANCE
IN THE
USA
* PAXMAN EXPECTS FDA TO BE ABLE TO COMPLETE APPLICATION
PROCESS
WITHOUT NEED FOR ADDITIONAL AMENDMENTS.
* APPLICATION SEEKS TO EXPAND USE OF COMPANY'S SCALP COOLING
Source text for Eikon: ID:nWkr1ytJ8h
Further company coverage: PAX.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Paxman AB (publ)
See all newsBrief: Paxman Secures First Uk Orders For Neuropathy System
Sweden's Paxman Q2 revenue rises 40% as net income turns positive
Brief: Paxman Reports Q2 Group Revenue Of SEK 105 Million
Brief: Paxman Says CMS Releases Cy2027 Proposed OPPS, MPFS Rules For Mechanical Scalp Cooling
Sweden's Paxman Q1 revenue rises 34% on Dignitana acquisition